• 32883 Citations
1984 …2027
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1984 2019

Filter
Article
98 Citations (Scopus)

Association of Hospital Procedure Volume and Outcomes in Patients with Colon Cancer at High Risk for Recurrence

Meyerhardt, J. A., Catalano, P. J., Schrag, D., Ayanian, J. Z., Haller, D. G., Mayer, R. J., Macdonald, J. S., Benson, A. B. & Fuchs, C. S., Oct 21 2003, In : Annals of Internal Medicine. 139, 8

Research output: Contribution to journalArticle

Colonic Neoplasms
Low-Volume Hospitals
Recurrence
High-Volume Hospitals
Survival
15 Citations (Scopus)

Association of survival with adherence to the American cancer society nutrition and physical activity guidelines for cancer survivors after colon cancer diagnosis the calgb 89803/alliance trial

Van Blarigan, E. L., Fuchs, C. S., Niedzwiecki, D., Zhang, S., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson III, A. B., Atienza, D., Messino, M., Kindler, H., Venook, A., Ogino, S., Giovannucci, E. L., Ng, K. & Meyerhardt, J. A., Jun 1 2018, In : JAMA Oncology. 4, 6, p. 783-790 8 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Survivors
Guidelines
Exercise
Confidence Intervals

Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)

Guercio, B. J., Zhang, S., Niedzwiecki, D., Li, Y., Babic, A., Morales-Oyarvide, V., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson III, A. B., Atienza, D., Messino, M., Kindler, H., Venook, A., Ogino, S., Zoltick, E. S., Stampfer, M., Ng, K. & 5 others, Wu, K., Willett, W. C., Giovannucci, E. L., Meyerhardt, J. A. & Fuchs, C. S., Jul 1 2018, In : PloS one. 13, 7, e0199244.

Research output: Contribution to journalArticle

Beverages
relapse
colorectal neoplasms
Colonic Neoplasms
beverages
12 Citations (Scopus)

Attitudinal barriers to participation in oncology clinical trials: Factor analysis and correlates of barriers

Manne, S., Kashy, D., Albrecht, T., Wong, Y. N., Lederman Flamm, A., Benson III, A. B., Miller, S. M., Fleisher, L., Buzaglo, J., Roach, N., Katz, M., Ross, E., Collins, M., Poole, D., Raivitch, S., Miller, D. M., Kinzy, T. G., Liu, T. & Meropol, N. J., Jan 1 2015, In : European Journal of Cancer Care. 24, 1, p. 28-38 11 p.

Research output: Contribution to journalArticle

Statistical Factor Analysis
Clinical Trials
Patient Participation
Neoplasms
Demography
15 Citations (Scopus)

A Web-based communication aid for patients with cancer: The CONNECT Study

Meropol, N. J., Egleston, B. L., Buzaglo, J. S., Balshem, A., Benson III, A. B., Cegala, D. J., Cohen, R. B., Collins, M., Diefenbach, M. A., Miller, S. M., Fleisher, L., Millard, J. L., Ross, E. A., Schulman, K. A., Silver, A., Slater, E., Solarino, N., Sulmasy, D. P., Trinastic, J. & Weinfurt, K. P., Apr 1 2013, In : Cancer. 119, 7, p. 1437-1445 9 p.

Research output: Contribution to journalArticle

Communication
Neoplasms
Physicians
Randomized Controlled Trials
Decision Making
41 Citations (Scopus)

Barriers to the use of personalized medicine in breast cancer

Weldon, C. B., Trosman, J. R., Gradishar, W. J., Benson III, A. B. & Schink, J. C., Jul 1 2012, In : Journal of oncology practice. 8, 4

Research output: Contribution to journalArticle

Precision Medicine
Breast Neoplasms
Molecular Pathology
Transcriptome
Insurance Carriers
6 Citations (Scopus)

BATON-CRC: A phase II randomized trial comparing tivozanib plus mFOLFOX6 with bevacizumab plus mFOLFOX6 in stage IV metastatic colorectal cancer

Benson III, A. B., Kiss, I., Bridgewater, J., Eskens, F. A. L. M., Sasse, C., Vossen, S., Chen, J., Van Sant, C., Ball, H. A., Keating, A. & Krivoshik, A., Oct 15 2016, In : Clinical Cancer Research. 22, 20, p. 5058-5067 10 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Disease-Free Survival
Neuropilin-1
Medical Futility
Biomarkers

Bevacizumab in colorectal cancer: Profile report

Goldberg, R. M. & Benson III, A. B., May 1 2005, In : Drugs and Therapy Perspectives. 21, 5, p. 5-6 2 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Bevacizumab
1765 Citations (Scopus)

Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200

Giantonio, B. J., Catalano, P. J., Meropol, N. J., O'Dwyer, P. J., Mitchell, E. P., Alberts, S. R., Schwartz, M. A. & Benson III, A. B., Apr 20 2007, In : Journal of Clinical Oncology. 25, 12, p. 1539-1544 6 p.

Research output: Contribution to journalArticle

oxaliplatin
Leucovorin
Fluorouracil
Colorectal Neoplasms
Survival
10 Citations (Scopus)

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers

Schink, J. C., Trosman, J. R., Weldon, C. B., Siziopikou, K. P., Tsongalis, G. J., Rademaker, A. W., Patel, J. D., Benson, A. B., Perez, E. A. & Gradishar, W. J., Oct 1 2014, In : Journal of the National Cancer Institute. 106, 10, dju256.

Research output: Contribution to journalArticle

National Cancer Institute (U.S.)
Lung Neoplasms
Breast
Biomarkers
Neoplasms
81 Citations (Scopus)

Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy

Sinicrope, F. A., Foster, N. R., Yothers, G., Benson, A., Seitz, J. F., Labianca, R., Goldberg, R. M., Degramont, A., O'Connell, M. J. & Sargent, D. J., Apr 15 2013, In : Cancer. 119, 8, p. 1528-1536 9 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Colonic Neoplasms
Body Mass Index
Clinical Trials
Survival
37 Citations (Scopus)

CALGB 80403 (Alliance)/E1206: A randomized phase II study of three chemotherapy regimens plus cetuximab in metastatic esophageal and gastroesophageal Junction Cancers

Enzinger, P. C., Burtness, B. A., Niedzwiecki, D., Ye, X., Douglas, K., Ilson, D. H., Villaflor, V. M., Cohen, S. J., Mayer, R. J., Venook, A., Benson, A. B. & Goldberg, R. M., Aug 10 2016, In : Journal of Clinical Oncology. 34, 23, p. 2736-2742 7 p.

Research output: Contribution to journalArticle

Esophagogastric Junction
irinotecan
Cisplatin
Drug Therapy
Epirubicin
85 Citations (Scopus)

Cancer patient preferences for quality and length of life

Meropol, N. J., Egleston, B. L., Buzaglo, J. S., Benson III, A. B., Cegala, D. J., Diefenbach, M. A., Fleisher, L., Miller, S. M., Sulmasy, D. P., Weinfurt, K. P., Balshem, A., Micco, E., Millard, J. L., Ross, E. A., Schulman, K. A., Slater, E., Solarino, N. & Trinastic, J., Dec 15 2008, In : Cancer. 113, 12, p. 3459-3466 8 p.

Research output: Contribution to journalArticle

Patient Preference
Quality of Life
Neoplasms
Communication
Decision Making
6 Citations (Scopus)

Care for a patient with cancer as a project: Management of complex task interdependence in cancer care delivery

Trosman, J. R., Carlos, R. C., Simon, M. A., Madden, D. L., Gradishar, W. J., Benson, A. B., Rapkin, B. D., Weiss, E. S., Gareen, I. F., Wagner, L. I., Khan, S. A., Bunce, M. M., Small, A. & Weldon, C. B., Nov 1 2016, In : Journal of oncology practice. 12, 11, p. 1101-1113 13 p.

Research output: Contribution to journalArticle

Patient Care
Neoplasms
Quality of Health Care
Ataxia
Outcome Assessment (Health Care)
21 Citations (Scopus)

Cetuximab plus chemoradiotherapy in immunocompetent patients with anal carcinoma: A phase II Eastern cooperative oncology group-American college of radiology imaging network cancer research group trial (E3205)

Garg, M. K., Zhao, F., Sparano, J. A., Palefsky, J., Whittington, R., Mitchell, E. P., Mulcahy, M. F., Armstrong, K. I., Nabbout, N. H., Kalnicki, S., El-Rayes, B. F., Onitilo, A. A., Moriarty, D. J., Fitzgerald, T. J. & Benson, A. B., Mar 1 2017, In : Journal of Clinical Oncology. 35, 7, p. 718-726 9 p.

Research output: Contribution to journalArticle

Chemoradiotherapy
Radiology
Anal Canal
Squamous Cell Carcinoma
Papillomaviridae
111 Citations (Scopus)

Chemoembolization for hepatocellular carcinoma: Comprehensive imaging and survival analysis in a 172-patient cohort

Lewandowski, R. J., Mulcahy, M. F., Kulik, L. M., Riaz, A., Ryu, R. K., Baker, T. B., Ibrahim, S. M., Abecassis, M. I., Miller, F. H., Sato, K. T., Senthilnathan, S., Resnick, S. A., Wang, E., Gupta, R., Chen, R., Newman, S. B., Chrisman, H. B., Nemcek, A. A., Vogelzang, R. L., Omary, R. A. & 2 others, Benson, A. B. & Salem, R., Jun 1 2010, In : Radiology. 255, 3, p. 955-965 11 p.

Research output: Contribution to journalArticle

Survival Analysis
Hepatocellular Carcinoma
Survival
Liver Neoplasms
Fibrosis
23 Citations (Scopus)
Yttrium
yttrium
Maximum Tolerated Dose
dosage
Liver
2 Citations (Scopus)

Chemotherapy: Adding oxaliplatin to the equation

Benson III, A. B., Nov 11 2009, In : Nature Reviews Clinical Oncology. 6, 11, p. 620-622 3 p.

Research output: Contribution to journalArticle

oxaliplatin
Organoplatinum Compounds
Local Neoplasm Recurrences
Antineoplastic Combined Chemotherapy Protocols
Leucovorin
13 Citations (Scopus)

Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (oltipraz) in patients with previously resected colon polyps and first-degree female relatives of breast cancer patients

Benson III, A. B., Olopade, O. I., Ratain, M. J., Rademaker, A. W., Mobarhan, S., Stucky-Marshall, L., French, S. & Dolan, M. E., Jan 1 2000, In : Clinical Cancer Research. 6, 10, p. 3870-3877 8 p.

Research output: Contribution to journalArticle

Polyps
Colon
Breast Neoplasms
Glutathione Transferase
Lymphocytes
56 Citations (Scopus)

Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: A multicenter retrospective chart review study

Strosberg, J. R., Benson III, A. B., Huynh, L., Duh, M. S., Goldman, J., Sahai, V., Rademaker, A. W. & Kulke, M. H., Jan 1 2014, In : Oncologist. 19, 9, p. 930-936 7 p.

Research output: Contribution to journalArticle

Octreotide
Neuroendocrine Tumors
Carcinoid Tumor
Medical Records
Diarrhea

Clinical roundtable monograph: A multidisciplinary approach to the management of hepatocellular carcinoma

Gish, R. G., Marrero, J. A. & Benson III, A. B., Mar 1 2010, In : Clinical Advances in Hematology and Oncology. 8, 3, p. 1-12 12 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Survival
Therapeutics
Liver Neoplasms
Complementary Therapies
26 Citations (Scopus)

Clodronate. A randomized study in the treatment of cancer-related hypercalcemia

Witte, R. S., Koeller, J., Davis, T. E., Benson, A. B., Durie, B. G., Lipton, A., Stock, J. L., Citrin, D. L. & Jacobs, T. P., Aug 3 1987, In : Archives of Internal Medicine. 147, 5, p. 937-939 3 p.

Research output: Contribution to journalArticle

Clodronic Acid
Second Primary Neoplasms
Hypercalcemia
Body Weight
Poisons
23 Citations (Scopus)

Coffee intake, recurrence, and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)

Guercio, B. J., Sato, K., Niedzwiecki, D., Ye, X., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson III, A. B., Atienza, D., Messino, M., Kindler, H., Venook, A., Hu, F. B., Ogino, S., Wu, K., Willett, W. C., Giovannucci, E. L., Meyerhardt, J. A. & 1 others, Fuchs, C. S., Nov 1 2015, In : Journal of Clinical Oncology. 33, 31, p. 3598-3607 10 p.

Research output: Contribution to journalArticle

Coffee
Colonic Neoplasms
Recurrence
Mortality
Tea
143 Citations (Scopus)

Colon cancer, version 3.2014

Benson III, A. B., Venook, A. P., Bekaii-Saab, T., Chan, E., Chen, Y. J., Cooper, H. S., Engstrom, P. F., Enzinger, P. C., Fenton, M. J., Fuchs, C. S., Grem, J. L., Hunt, S., Kamel, A., Leong, L. A., Lin, E., Messersmith, W., Mulcahy, M. F., Murphy, J. D., Nurkin, S., Rohren, E. & 11 others, Ryan, D. P., Saltz, L., Sharma, S., Shibata, D., Skibber, J. M., Sofocleous, C. T., Stoffel, E. M., Stotsky-Himelfarb, E., Willett, C. G., Gregory, K. M. & Freedman-Cass, D. A., Jul 1 2014, In : JNCCN Journal of the National Comprehensive Cancer Network. 12, 7, p. 1028-1059 32 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Guidelines
Therapeutics
Continuity of Patient Care
Patient Preference
25 Citations (Scopus)

Colon cancer.

Benson, A. B., Arnoletti, J. P., Bekaii-Saab, T., Chan, E., Chen, Y. J., Choti, M. A., Cooper, H. S., Dilawari, R. A., Engstrom, P. F., Enzinger, P. C., Fleshman, J. W., Fuchs, C. S., Grem, J. L., Knol, J. A., Leong, L. A., Lin, E., May, K. S., Mulcahy, M. F., Murphy, K., Rohren, E. & 10 others, Ryan, D. P., Saltz, L., Sharma, S., Shibata, D., Skibber, J. M., Small, W., Sofocleous, C. T., Venook, A. P., Willett, C. & National Comprehensive Cancer Network, C. C. N., Nov 1 2011, In : Journal of the National Comprehensive Cancer Network : JNCCN. 9, 11, p. 1238-1290 53 p.

Research output: Contribution to journalArticle

Digestive System Surgical Procedures
Antineoplastic Combined Chemotherapy Protocols
Maintenance Chemotherapy
Combined Modality Therapy
Neoadjuvant Therapy
26 Citations (Scopus)

Colon cancer. Clinical practice guidelines in oncology.

Engstrom, P. F., Benson, A. B., Saltz, L. & National Comprehensive Cancer Network, C. C. N., Jan 1 2003, In : Journal of the National Comprehensive Cancer Network : JNCCN. 1, 1, p. 40-53 14 p.

Research output: Contribution to journalArticle

Practice Guidelines
Colonic Neoplasms
irinotecan
Fluorouracil
oxaliplatin
430 Citations (Scopus)

Colorectal cancer surveillance: 2005 Update of an American Society of Clinical Oncology practice guideline

Desch, C. E., Benson, A. B., Somerfield, M. R., Flynn, P. J., Krause, C., Loprinzi, C. L., Minsky, B. D., Pfister, D. G., Virgo, K. S. & Petrelli, N. J., Dec 1 2005, In : Journal of Clinical Oncology. 23, 33, p. 8512-8519 8 p.

Research output: Contribution to journalArticle

Practice Guidelines
Colorectal Neoplasms
Rectal Neoplasms
Thorax
Tomography
76 Citations (Scopus)

Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer

Kaufman, H. L., Lenz, H. J., Marshall, J., Singh, D., Garett, C., Cripps, C., Moore, M., Von Mehren, M., Dalfen, R., Heim, W. J., Conry, R. M., Urba, W. J., Benson III, A. B., Yu, M., Caterini, J., Kim-Schulze, S., DeBenedette, M., Salha, D., Vogel, T., Elias, I. & 1 others, Berinstein, N. L., Aug 1 2008, In : Clinical Cancer Research. 14, 15, 1 p.

Research output: Contribution to journalArticle

Carcinoembryonic Antigen
Combination Drug Therapy
Colorectal Neoplasms
Vaccines
Drug Therapy
4 Citations (Scopus)

Combination chemotherapy of advanced breast cancer. Comparison of dibromodulcitol, doxorubicin, vincristine, and fluoxymesterone to thiotepa, doxorubicin, vinblastine, and fluoxymesterone: An eastern cooperative oncology group study

Skeel, R. T., Andersen, J. W., Tormey, D. C., Benson III, A. B., Asbury, R. F. & Falkson, G., Jan 1 1989, In : Cancer. 64, 7, p. 1393-1399 7 p.

Research output: Contribution to journalArticle

Mitolactol
Fluoxymesterone
Thiotepa
Vinblastine
Vincristine
352 Citations (Scopus)

Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - An intergroup study

Kemeny, M. M., Adak, S., Gray, B., Macdonald, J. S., Smith, T., Lipsitz, S., Sigurdson, E. R., O'Dwyer, P. J. & Benson, A. B., Mar 15 2002, In : Journal of Clinical Oncology. 20, 6, p. 1499-1505 7 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Neoplasm Metastasis
Drug Therapy
Liver
Recurrence
5 Citations (Scopus)

Comparing the cost of treatment with octreotide long-acting release versus lanreotide in patients with metastatic gastrointestinal neuroendocrine tumors

Ayyagari, R., Neary, M., Li, S., Rokito, A., Yang, H., Xie, J. & Benson, A. B., Nov 1 2017, In : American Health and Drug Benefits. 10, 8, p. 408-415 8 p.

Research output: Contribution to journalArticle

Octreotide
Neuroendocrine Tumors
Health Care Costs
Costs and Cost Analysis
Drug Costs
Open Access
Nonprofit Organizations
Neoplasms
Patient Education
Lymphoma
Lung Neoplasms
39 Citations (Scopus)

Concordance with NCCN colorectal cancer guidelines and ASCO/NCCN quality measures: An NCCN institutional analysis

Romanus, D., Weiser, M. R., Skibber, J. M., Ter Veer, A., Niland, J. C., Wilson, J. L., Rajput, A., Wong, Y. N., Benson III, A. B., Shibata, S. & Schrag, D., Jan 1 2009, In : JNCCN Journal of the National Comprehensive Cancer Network. 7, 8, p. 895-904 10 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Guidelines
Neoplasms
Databases
Rectal Neoplasms
7 Citations (Scopus)

Correlations between leukocyte count and absolute granulocyte count in patients receiving cancer chemotherapy

Benson, A. B., Read, T. R. C., Goebel, S. L., Koeller, J. M. & Tormey, D. C., Jan 1 1985, In : Cancer. 56, 6, p. 1350-1355 6 p.

Research output: Contribution to journalArticle

Leukocyte Count
Granulocytes
Drug Therapy
Neoplasms
Drug-Related Side Effects and Adverse Reactions
1 Citation (Scopus)

Cost reduction from resolution/improvement of carcinoid syndrome symptoms following treatment with above-standard dose of octreotide LAR

Huynh, L., Totev, T., Vekeman, F., Neary, M. P., Duh, M. S. & Benson III, A. B., Sep 2 2017, In : Journal of Medical Economics. 20, 9, p. 945-951 7 p.

Research output: Contribution to journalArticle

Octreotide
Carcinoid Tumor
Diarrhea
Neuroendocrine Tumors
Costs and Cost Analysis
7 Citations (Scopus)

Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: The National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI)

Butt, Z., Parikh, N. D., Beaumont, J. L., Rosenbloom, S. K., Syrjala, K. L., Abernethy, A. P., Benson III, A. B. & Cella, D., Dec 1 2012, In : Cancer. 118, 23, p. 5997-6004 8 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Neoplasms
Therapeutics
Bile Duct Neoplasms
Physicians
1 Citation (Scopus)

Dietary fat intake after colon cancer diagnosis in relation to cancer recurrence and survival: CALGB 89803 (Alliance)

Van Blarigan, E. L., Ou, F. S., Niedzwiecki, D., Zhang, S., Fuchs, C. S., Saltz, L., Mayer, R. J., Venook, A., Ogino, S., Song, M., Benson III, A. B., Hantel, A., Atkins, J. N., Giovannucci, E. L. & Meyerhardt, J. A., Oct 1 2018, In : Cancer Epidemiology Biomarkers and Prevention. 27, 10, p. 1227-1230 4 p.

Research output: Contribution to journalArticle

Dietary Fats
Colonic Neoplasms
Recurrence
Survival
Vegetables
84 Citations (Scopus)

Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803

Meyerhardt, J. A., Sato, K., Niedzwiecki, D., Ye, C., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson III, A. B., Wigler, D. S., Venook, A. & Fuchs, C. S., Nov 21 2012, In : Journal of the National Cancer Institute. 104, 22, p. 1702-1711 10 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Recurrence
Survival
Neoplasms
Disease-Free Survival

Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance)

Morales-Oyarvide, V., Yuan, C., Babic, A., Zhang, S., Niedzwiecki, D., Brand-Miller, J. C., Sampson-Kent, L., Ye, X., Li, Y., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson III, A. B., Atienza, D., Messino, M., Kindler, H., Venook, A., Ogino, S. & 7 others, Wu, K., Willett, W. C., Giovannucci, E. L., Wolpin, B. M., Meyerhardt, J. A., Fuchs, C. S. & Ng, K., Feb 1 2019, In : Journal of the National Cancer Institute. 111, 2, p. 170-179 10 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Insulin
Recurrence
Survival
Neoplasms
3 Citations (Scopus)

Discussion: Diagnostic issues in early-stage disease

Compton, C., Chang, K., Benson, A., Haller, D., Lynch, P., Nelson, H., Stamos, M., Rosen, L., Beart, R., Grothey, A. & Bilchik, A., Nov 15 2007, In : Clinical Cancer Research. 13, 22

Research output: Contribution to journalArticle

Discussion: Issues in adjuvant therapy for early-stage disease

Grothey, A., Haller, D., Willett, C., Rosen, L., Beart, R., Stamos, M., Bilchik, A. & Benson, A., Nov 15 2007, In : Clinical Cancer Research. 13, 22

Research output: Contribution to journalArticle

Therapeutics

Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long-Term Follow-Up

Rosenberg, A. J., Rademaker, A. W., Hochster, H. S., Ryan, T., Hensing, T., Shankaran, V., Baddi, L., Mahalingam, D., Mulcahy, M. F. & Benson III, A. B., Jan 1 2019, In : Oncologist. 24, 8, p. 1039-e642

Research output: Contribution to journalArticle

oxaliplatin
docetaxel
Esophagogastric Junction
Fluorouracil
Stomach
41 Citations (Scopus)

Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: Results from CALGB 9581

Niedzwiecki, D., Bertagnolli, M. M., Warren, R. S., Compton, C. C., Kemeny, N. E., Benson, A. B., Eckhardt, S. G., Alberts, S., Porjosh, G. N., Kerr, D. J., Anthony, Fields, Rougier, P., Pipas, J. M., Schwartz, J. H., Atkins, J., O'Rourke, M., Perry, M. C., Goldberg, R. M., Mayer, R. J. & 1 others, Colacchio, T. A., Aug 10 2011, In : Journal of Clinical Oncology. 29, 23, p. 3146-3152 7 p.

Research output: Contribution to journalArticle

Natural History
Colon
Adenocarcinoma
Observation
Survival
2 Citations (Scopus)

E4206: AMG 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors

Lubner, S., Feng, Y., Mulcahy, M. F., O'Dwyer, P., Giang, G. Y., Hinshaw, J. L., Deming, D., Klein, L., Teitelbaum, U., Payne, J., Engstrom, P., Stella, P., Meropol, N. & Benson III, A. B., Sep 1 2018, In : Oncologist. 23, 9, p. 1006-e104

Research output: Contribution to journalArticle

Octreotide
Neuroendocrine Tumors
Disease-Free Survival
Vascular Endothelial Growth Factor A
Fatigue
113 Citations (Scopus)

Eastern Cooperative Oncology Group, phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity

Talamonti, M. S., Catalano, P. J., Vaughn, D. J., Whittington, R., Beauchamp, R. D., Berlin, J. & Benson III, A. B., Oct 1 2000, In : Journal of Clinical Oncology. 18, 19, p. 3384-3389 6 p.

Research output: Contribution to journalArticle

gemcitabine
Pancreatic Neoplasms
Fluorouracil
Radiotherapy
Radiation
6 Citations (Scopus)
irinotecan
radiology
Radiology
Cisplatin
radiation therapy
13 Citations (Scopus)

Eastern cooperative oncology group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancer

Marsh, J. C., Catalano, P., Huang, J., Graham, D. L., Cornfeld, M. J., O'Dwyer, P. J. & Benson III, A. B., Jan 1 2002, In : Clinical colorectal cancer. 2, 1, p. 43-50 8 p.

Research output: Contribution to journalArticle

Fluorouracil
Colorectal Neoplasms
eniluracil
Phase II Clinical Trials
Stomatitis
166 Citations (Scopus)

Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer a randomized clinical trial

Venook, A. P., Niedzwiecki, D., Lenz, H. J., Innocenti, F., Fruth, B., Meyerhardt, J. A., Schrag, D., Greene, C., O'Neil, B. H., Atkins, J. N., Berry, S., Polite, B. N., O'Reilly, E. M., Goldberg, R. M., Hochster, H. S., Schilsky, R. L., Bertagnolli, M. M., El-Khoueiry, A. B., Watson, P., Benson III, A. B. & 3 others, Mulkerin, D. L., Mayer, R. J. & Blanke, C., Jun 20 2017, In : JAMA - Journal of the American Medical Association. 317, 23, p. 2392-2401 10 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Randomized Controlled Trials
Drug Therapy
Survival
oxaliplatin
22 Citations (Scopus)

Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer

Earle, C. C., Weiser, M. R., Ter Veer, A., Skibber, J. M., Wilson, J., Rajput, A., Wong, Y. N., Benson III, A. B., Shibata, S., Romanus, D., Niland, J. & Schrag, D., Dec 1 2009, In : Journal of Surgical Oncology. 100, 7, p. 525-528 4 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Colonic Neoplasms
Lymph Nodes
Benchmarking
oxaliplatin
67 Citations (Scopus)

Epidermal growth factor receptor-targeted therapy in colorectal cancer

O'Dwyer, P. J. & Benson III, A. B., Jan 1 2002, In : Seminars in Oncology. 29, 5, p. 10-17 8 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Colorectal Neoplasms
Therapeutics
Immunotoxins
Growth Inhibitors